Oxymatrine, an isolated extract from traditional Chinese herb Sophora Flavescens Ait,
has been traditionally used for therapy of anti-hepatitis B virus,
anti-inflammation and anti-anaphylaxis. The present study was to
investigate the anti-cancer effect of oxymatrine on human pancreatic
cancer PANC-1 cells, and its possible molecular mechanism.
The
long-term consequences of failed interferon-alpha based hepatitis C
treatment on liver morbidity and survival have not been fully explored.
We performed retrospective analyses to assess long-term clinical
outcomes among treated and untreated patients with hepatitis C virus in
two independent cohorts from a United States Veterans Affairs Medical
Center and a University Teaching Hospital. Eligible patients underwent
liver biopsy during consideration for interferon-alpha based treatment
between 1992 and 2007.
Dr. Ed Park is an expert in stem cells an telomerase. Here he discusses what aging is and what it happening at the cellular level, that causes our bodies to slowly break down and age over time.
Being diagnosed with a potentially fatal disease usually triggers
immediate treatment. But a growing number of people infected with
hepatitis C are putting off therapy, choosing instead to roll the dice
and wait for a new generation of drugs to become available.
Over the past forty years, intensive chemical, pharmacological and
clinical research has confirmed the mechanisms of action and therapeutic
value of milk thistle in a wide range of human liver-related and
non-liver-related conditions. Literally hundreds of modern research
studies have confirmed the remarkable ability of milk thistle to protect
the liver and the body against virtually all types of damage.
German researchers have determined that epigallocatechin-3-gallate
(EGCG)—a flavonoid found in green tea—inhibits the hepatitis C virus
(HCV) from entering liver cells. Study findings available in the
December issue of Hepatology, a journal published by
Wiley-Blackwell on behalf of the American Association for the Study of
Liver Diseases, suggest that EGCG may offer an antiviral strategy to
prevent HCV reinfection following liver transplantation.
